FdaApplication
ANDA 211826
Identifiers
- fda_app_no: ANDA211826
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2025-05-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GEFITINIB | GEFITINIB | 250MG | TABLET;ORAL |
1 product